Vanberra Signal

OrthoGrid Systems

Curated by Signal

Surgical guidance systems for orthopedic surgeries

Overview

OrthoGrid Systems provides surgical guidance systems that make radiopaque grid patterns to aid surgeons in orthopaedic surgery. OrthoGrid works by attaching to the inside of the sterile cover of a 9" or 12" C-arm. Once in place, the orientation and position of the grid pattern can be fine-tuned over the appropriate anatomical landmarks to visualize and assess implant positioning and anatomic alignment. Their intraoperative guides are used for joint reconstruction, arthroplasty, and trauma. As of October 2016, currently available products include The Hip Guard Drone for Direct Anterior Total Hip Arthroplasty & Posterior Approach Total Hip Arthroplasty. The company plans to introduce grids for Shoulder, Knee, Wrist, and Ankle in the future.

Key facts

Founded
2011

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Genomic analysis and machine learning to identify early drug resistance and for precision drug therapies.

    Life Sciences TechnologySan Diego, United States
  • Provider of assay reagents kits and gene panels for epigenetics, genome assembly and research purposes

    Life Sciences TechnologySanta Cruz, United States
  • Digital electromyography data reporting tool for providers

    Life Sciences TechnologyPhoenix, United States

About OrthoGrid Systems

What does OrthoGrid Systems do?

OrthoGrid Systems provides surgical guidance systems that make radiopaque grid patterns to aid surgeons in orthopaedic surgery.

Where is OrthoGrid Systems headquartered?

OrthoGrid Systems is headquartered in Salt Lake City, United States.

When was OrthoGrid Systems founded?

OrthoGrid Systems was founded in 2011.

Which sector is OrthoGrid Systems in?

OrthoGrid Systems operates in Life Sciences Technology.

Who are OrthoGrid Systems's competitors?

Companies similar to OrthoGrid Systems include DNA SEQ Alliance, Dovetail Genomics, and Noraxon.